Table 4.
Case | Age (Years) | Sex | Apoptag | p53 | Bcl-2 | Mib-1 (Ki-67) | CD95 (fas) |
---|---|---|---|---|---|---|---|
1 | 62 | M | 0 | 2+ | 4+ | 4+ | 0 |
2 | 74 | M | 0 | 1+ | 3+ | 2–3+ | 4+ |
3 | 46 | M | 0 | 1+ | 4+ | 1+ | 1+ |
4 | 73 | F | 0 | 4+ | 0 | 1+ | 3+ |
5 | 58 | F | 0 | 1+ | 4+ | 1+ | 0 |
6 | 57 | M | 0 | 2+ | 0 | 2+ | 4+ |
7 | 56 | F | 0 | 1+ | 1+ | 1+ | 0 |
8 | 66 | M | 0 | 2+ | 3+ | 3+ | 1+ |
9 | 56 | M | 0 | 1+ | 4+ | 2+ | 0 |
10 | 52 | M | 0 | 1+ | 4+ | 1+ | 0 |
11 | 50 | F | 0 | 4+ | 1+ | 2+ | 3+ |
12 | 54 | F | 0 | 3+ | 4+ | 2+ | 0 |
Initial neoplasm in case 6 was a DLBCL; patient had relapsed lymphoma 7 years later with a TCRBCL pattern (case 12 in Tables 1 and 3 ▶ ▶ ). The initial neoplasm in case 7 also was a DLBCL, with a relapse 8 years later with a TCRBCL pattern (case 10 in Tables 1 and 3 ▶ ▶ ). See Table 3 ▶ for scoring system. M, male; F, female.